Form D · Pharmaceuticals
DBV Technologies S.A.
Chatillon, I0 · CIK 0001613780
Offering snapshot reported Apr 17, 2025 · SEC filing
- Reported sold
- $307M Offering amount: $307M
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 7, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 17, 2025 | Initial | $306,900,000 | No comparison | 14 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $18.4M
- Finders' fees
- $0
- Form D file number
- 021-543990
Approximately $12.2 million of sales commissions is contingent on the exercise of warrants.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| LifeSci Capital LLC | 168404 | |
| Van Lanschot Kempen NV | None | |
| Van Lanschot Kempen (USA) Inc. | 38760 |
Source: Form D, filed Apr 17, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Virginie Boucinha | Executive |
| Michel De Rosen | Director |
| Mailys Ferrere | Director |
| Michael Goller | Director |
| Daniele Guyot Caparros | Director |
| Pharis Mohideen | Executive |
| Timothy E. Morris | Director |
| Adora Ndu | Director |
| Julie O'neill | Director |
| Ravi Madduri Rao | Director |
| Daniel Soland | Director |
| Daniel Tasse | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
107 Avenue De La Republique
Chatillon, I0, 92320
Phone: 33(0)155427878
Chatillon, I0, 92320
Phone: 33(0)155427878